Monitoring of Plasma Ferritin Levels after Blood Transfusions in Patients with Myelodysplastic Syndromes

被引：0
|
作者：
Rozema, Johanne [1 ,2 ]
Van Asten, Ivar [3 ]
Kwant, Beau [1 ]
Kibbelaar, Robby E. [4 ]
Veeger, Nic J. G. M. [5 ,6 ]
De Wit, Harry [3 ]
Van Roon, Eric N. [1 ,2 ]
Hoogendoorn, Mels [7 ]
机构：
[1] Univ Groningen, Dept Pharm, Groningen, Netherlands
[2] Med Ctr Leeuwarden, Dept Clin Pharm & Pharmacol, Leeuwarden, Netherlands
[3] Locat Med Ctr Leeuwarden, Certe Med Diagnost & Advice, Leeuwarden, Netherlands
[4] Pathol Friesland, Leeuwarden, Netherlands
[5] Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[6] Med Ctr Leeuwarden, Sci Bur, Leeuwarden, Netherlands
[7] Dept Internal Med, Med Ctr Leeuwarden, Leeuwarden, Netherlands
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152096
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1986
引用
收藏
页码：1986 / +
页数：3
相关论文
共 50 条
  • [41] ANTIHEMOPHILIC FACTOR (AHF) LEVELS FOLLOWING TRANSFUSIONS OF BLOOD, PLASMA AND PLASMA FRACTIONS
    LANGDELL, RD
    WAGNER, RH
    BRINKHOUS, KM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1955, 88 (02): : 212 - 215
  • [42] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [43] LYMPHOCYTE SUBPOPULATIONS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    CALAVREZOS, A
    ARNDT, R
    KUSE, R
    BLUT, 1986, 53 (03): : 234 - 234
  • [44] Alloinnumunization after red blood cell transfusion in myelodysplastic syndromes (MDS)
    Sanz, CC
    Abello, D
    Pereira, A
    TRANSFUSION, 2004, 44 (09) : 120A - 120A
  • [45] Outcomes After Cord Blood Transplantation for Pediatric Myelodysplastic Syndromes in Japan
    Yoshida, Nao
    Watanabe, Kenichiro
    Hama, Asahito
    Yamamoto, Shohei
    Noguchi, Maiko
    Sasahara, Yoji
    Sakaguchi, Hirotoshi
    Hashii, Yoshiko
    Sato, Atsushi
    Atsuta, Yoshiko
    Hasegawa, Daiichiro
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S46 - S46
  • [46] Deferasirox (ICL670; Exjade®) reduces serum ferritin (SF) and labile plasma iron (LPI) in patients with myelodysplastic syndromes (MDS)
    List, Alan F.
    Baer, M. R.
    Steensma, D.
    Raza, A.
    Esposito, J.
    Virkus, J.
    Feigert, J.
    Besa, E.
    Paley, C.
    BLOOD, 2007, 110 (11) : 440A - 440A
  • [47] IMPACT OF PRE-AZACITIDINE SERUM FERRITIN ON RESPONSE AND OVERALL SURVIVAL ON PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Garcia, R.
    De Miguel, D.
    Bailen, A.
    Gonzalez, J.
    Bargay, J.
    Falantes, J.
    Andreu, R.
    Ramos, F.
    Tormo, M.
    Duarte, R.
    Jimenez Lorenzo, M.
    Brunet, S.
    Nomdedeu, B.
    Figueredo, A.
    Casano, J.
    Badiella, L.
    Fernandez Jurado, A.
    Sanz, G.
    HAEMATOLOGICA, 2012, 97 : 364 - 365
  • [48] Changes in Premature Infant Mercury and Lead Blood Levels after Blood Transfusions
    Elabiad, Mohamad T.
    Christensen, Michael
    AMERICAN JOURNAL OF PERINATOLOGY, 2014, 31 (10) : 863 - 867
  • [49] INCREASED SERUM INTERLEUKIN-6 LEVELS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    HEROLD, M
    SCHMALZL, F
    ZWIERZINA, H
    LEUKEMIA RESEARCH, 1992, 16 (6-7) : 585 - 588
  • [50] Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes (MDS).
    Sudhoff, T
    Wehmeier, A
    Aul, C
    BLOOD, 1997, 90 (10) : 4051 - 4051
12345